Innovent Biologics, Inc. (1801.HK) stock analysis

In our weekly check, Innovent Biologics, Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 13 pass, warnings: 5, red flags: 5.

About Innovent Biologics, Inc.

Innovent Biologics, Inc. is a Healthcare company (Biotechnology) based in China, listed on HKSE as 1801.HK.

What our checks show for 1801.HK

Red flags

• Operating profit covers interest only 1.4 times: a weak year could make the payments hard.
• The gross margin fell by 9.9 points, to 76.7%: costs are rising faster than prices.
• The price is 99.8 times earnings (P/E): the market already pays for a lot of future growth.
• The stock has fallen as much as 82% from a peak. Would you have held through that?
• Recovering from its deepest fall took about 3.2 years.

Warning signs

• Earnings per share fell 31% a year over the last 3 years.
• The net margin is only 6.2%: little room if costs rise.
• The price swings a lot: 45.9% annual volatility. Expect large ups and downs.
• The share count grew by 11% in 2 years: each shareholder owns a smaller slice.
• Return on capital (ROCE) is only 5.8%.

Strengths

• Debt is low: 0.11x equity.
• The net margin rose by 70.1 points over 5 years, to 6.2%.
• Operating cash flow is 12.29x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 83.5% a year over the next years.
• Analysts expect revenue to grow about 29.1% a year over the next years.
• Analysts expect the net margin to improve by 8.1 points from today's 6.2%.

Similar companies

VRTX · 2269.HK · CSL.AX · REGN · MRNA · 9926.HK

Questions

What grade does Innovent Biologics, Inc. (1801.HK) have?

In our weekly check, Innovent Biologics, Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 13 pass, warnings: 5, red flags: 5. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of 1801.HK stock?

This week's biggest flags for Innovent Biologics, Inc.: Weak interest cover, Gross margin falling, High P/E. In total 10 of 23 checks show a warning or a red flag.

What does Innovent Biologics, Inc. do?

Innovent Biologics, Inc. is a Healthcare company (Biotechnology) based in China, listed on HKSE as 1801.HK.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis